EU approves COVID-19 drug Remdesivir
EU approves COVID-19 drug Remdesivir.
The European Union has approved the use of anti-viral drug remdesivir to treat severe cases of COVID-19.
The European Union Health Commissioner Stella Kyriakides made this announcement on Friday July 3, days after the US effectively stockpiled the world’s entire supply of the antiviral medication. Its approval came after two major US studies showed that remdesivir can reduce the duration of hospital stay for COVID-19 patients.
Stella Kyriakides in a Statement said:
Remdesivir is the only medically approved Vaccine for the treatment of coronavirus in the EU and was given green light.
The green light comes on the recomendation of the European Medicines Agency which gave its conditional authorisation last week for the treatment of patients above 12 years of age who are suffering pneumonia and require extra oxygen.
It said its assessment was based mainly based on data from a study sponsored by the US National Institute of Allergy and Infectious Diseases (NIAID).
This update that EU approves COVID-19 drug Remdesivir is brought to you by 9jatalkative
9jatalkative will continue to bring you more breaking news as they break all over the country and the world at large
More updates coming up soon and please don’t forget to follow 9jatalkative on social media